RNA Analysis / Transcriptomics

Global Market Trajectory & Analytics

MCP15286

EXECUTIVE ENGAGEMENTS

POOL

2833
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

512
Interactions with Platform & by Email

PARTICIPANTS

83
Unique # Participated

VALIDATIONS

24
Responses Validated*

COMPANIES

42
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

159

PAGES

231

EDITION

7

PRICE

USD 4950

CODE

MCP15286


COMPETITIVE METRICS

COMPANY

D S N T

% *

Affymetrix, Inc.

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

F. Hoffmann-La Roche AG

Fluidigm Corporation

GE Healthcare

Illumina, Inc.

MilliporeSigma

QIAGEN GmbH

Thermo Fisher Scientific, Inc.

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for RNA Analysis / Transcriptomics estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$11.8 Billion by 2027, growing at a CAGR of 14.1% over the analysis period 2020-2027.Reagents / Consumables, one of the segments analyzed in the report, is projected to grow at a 15.4% CAGR to reach US$5.9 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 12.5% CAGR for the next 7-year period. This segment currently accounts for a 30.1% share of the global RNA Analysis / Transcriptomics market.
The RNA Analysis / Transcriptomics market in the U.S. is estimated at US$1.8 Billion in the year 2020. The country currently accounts for a 39.34% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1 Billion in the year 2027 trailing a CAGR of 15.6% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.9% and 14.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR while Rest of European market (as defined in the study) will reach US$1 Billion by the year 2027.
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 14.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$744.8 Million in the year 2020 will reach a projected size of US$1.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$737.3 Million by the year 2027.

SELECT PLAYERS

Affymetrix, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Fluidigm Corporation; GE Healthcare; Illumina, Inc.; MilliporeSigma; Qiagen NV; Thermo Fisher Scientific, Inc.

SEGMENTS

» Product (Reagents / Consumables, Instruments, Services, Software) » Technology (Polymerase Chain Reaction, Sequencing, Microarray, RNA Interference) » Application (Drug Discovery, Toxicogenomics, Clinical Diagnostics, Comparative Transcriptomics)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Transcriptomics Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Transcriptomics Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Transcriptomics Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Polymerase chain reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Polymerase chain reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Polymerase chain reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Sequencing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Sequencing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Sequencing Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmaceutical and biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical and biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical and biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Academic Research and Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Academic Research and Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic Research and Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
China Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
China Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Transcriptomics Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Transcriptomics Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Transcriptomics Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
France Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
France Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
Total Companies Profiled: 42

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com